Apalutamide, Abiraterone Acetate, and Prednisone for the Treatment of Metastatic High Risk Castration Sensitive Prostate Cancer
Conditions: Castration-Sensitive Prostate Carcinoma; Metastatic Prostate Carcinoma; Stage IV Prostate Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8; Stage IVB Prostate Cancer AJCC v8 Interventions: Drug: Abiraterone Acetate; Drug: Antiandrogen Therapy; Drug: Apalutamide; Drug: Prednisone; Other: Quality-of-Life Assessment; Other: Questionnaire Administration Sponsors: OHSU Knight Cancer Institute; National Cancer Institute (NCI); Oregon Health and Science University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Abiraterone Acetate | Cancer | Cancer & Oncology | Carcinoma | Prednisone | Prostate Cancer | Research